BRIVARACETAM PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
The present disclosure provides a brivaracetam pharmaceutical composition, a preparation method therefor and use thereof. The pharmaceutical composition comprises an active pharmaceutical ingredient, a matrix forming agent, and a swelling agent. The brivaracetam pharmaceutical composition disclosed herein has a sustained release effect and has a more flat release curve compared with a common gel skeleton sustained-release preparation, and thus achieves the purposes of reducing the release rate of the medicament, controlling the in vivo effective dosage of the medicament, stabilizing the blood concentration, reducing toxic and side effects and reducing the times of daily administration..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 28. Dez. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
GUO ZHEN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-12-28, Last update posted on www.tib.eu: 2024-02-27, Last updated: 2024-03-01 |
|---|
| Patentnummer: |
EP3964201 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA015504492 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA015504492 | ||
| 003 | DE-627 | ||
| 005 | 20240301101941.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA015504492 | ||
| 035 | |a (EPA)EP3964201 | ||
| 035 | |a (EPA)79232864 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a GUO ZHEN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a BRIVARACETAM PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-12-28, Last update posted on www.tib.eu: 2024-02-27, Last updated: 2024-03-01 | ||
| 520 | |a The present disclosure provides a brivaracetam pharmaceutical composition, a preparation method therefor and use thereof. The pharmaceutical composition comprises an active pharmaceutical ingredient, a matrix forming agent, and a swelling agent. The brivaracetam pharmaceutical composition disclosed herein has a sustained release effect and has a more flat release curve compared with a common gel skeleton sustained-release preparation, and thus achieves the purposes of reducing the release rate of the medicament, controlling the in vivo effective dosage of the medicament, stabilizing the blood concentration, reducing toxic and side effects and reducing the times of daily administration. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CHEN LINA |4 aut | |
| 700 | 0 | |a WEN YIFENG |4 aut | |
| 700 | 0 | |a WANG TINGTING |4 aut | |
| 700 | 0 | |a YING SHUHUAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 28. Dez. |
| 773 | 1 | 8 | |g year:2022 |g day:28 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/79232864/publication/EP3964201A1?q=EP3964201 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 28 |c 12 | ||